Adaptive Biotechnologies reports annual meeting outcomes

Adaptive Biotechnologies just wrapped up its annual meeting, and the key takeaways are in. The company shared updates on its progress in immune-driven medicine, including advancements in diagnostics and therapeutics. While they highlighted some promising developments, there weren’t any major surprises or groundbreaking announcements—just steady forward momentum.